Follow-up category | Patients with ALL | Patients with OSC | Total population | ||
---|---|---|---|---|---|
N (mean FS ± SD) | N (mean FS ± SD) | N (mean FS ± SD) | Decreased not decreased FS, N1 | OR (95% CI) 2 | |
At the diagnosis | 358 | 29 | 387 | ||
41.5 ± 6.1 | 39.6 ± 4.4 | 41.4 ± 6.0 | |||
< 1 yr. from diagnosis1 | 275 | 5 | 280 | 104 | 83 | 1.0 |
40.4 ± 6.1 | 40.2 ± 5.3 | 40.4 ± 6.1 | |||
1–2 yr. from diagnosis | 46 | 3 | 49 | 19 | 10 | 1.5 (0.6–3.4) |
41.4 ± 6.0 | 39.9 ± 2.3 | 41.3 ± 5.9 | |||
End of the treatment | 287 | 28 | 315 | 105 | 98 | 0.9 (0.6–1.3) |
40.0 ± 5.6 | 38.4 ± 6.3 | 39.9 ± 5.7 | |||
2–5 yr. from diagnosis | 229 | 35 | 264 | 77 | 73 | 0.8 (0.5–1.3) |
40.4 ± 5.7 | 38.1 ± 5.2 | 40.1 ± 5.7 | |||
5–10 yr. from diagnosis | 265 | 36 | 301 | 70 | 76 | 0.7 (0.5–1.1) |
40.1 ± 5.5 | 40.3 ± 5.6 | 40.1 ± 5.5 | |||
10–15 yr. from diagnosis | 133 | 19 | 152 | 24 | 36 | 0.5 (0.3–1.0) |
40.4 ± 5.4 | 39.9 ± 5.2 | 40.3 ± 5.3 | |||
> 15 yr. from diagnosis | 24 | 8 | 32 | 5 | 3 | 1.3 (0.3–5.7) |
37.6 ± 7.5 | 40.7 ± 6.1 | 38.4 ± 7.2 |